X
Get new exclusive access to healthcare business reports & breaking news
Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.
After positive data in an early-stage trial, AbbVie and Genmab plan to ask the Food and Drug Administration ...
More than a year since AbbVie first announced its intentions to acquire Botox maker, Allergan, for $63 billion, ...
After facing shareholder pressure to either break up the company or sell it, Allergan Chairman and Chief Executive ...
AbbVie has granted Pfizer a non-exclusive license to market its Humira (adalimumab) biosimilar in the U.S., which will ...
Mission Therapeutics (“Mission”), a drug creator company focused on selectively targeting deubiquitylating enzymes (DUBs) and Chicago-based AbbVie (“AbbVie”), ...
On November 13th, Chicago-based AbbVie, a research-based global biopharmaceutical company, released new findings on its pan-genotypic chronic hepatitis C ...
